ES8608872A1 - Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada. - Google Patents

Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.

Info

Publication number
ES8608872A1
ES8608872A1 ES536167A ES536167A ES8608872A1 ES 8608872 A1 ES8608872 A1 ES 8608872A1 ES 536167 A ES536167 A ES 536167A ES 536167 A ES536167 A ES 536167A ES 8608872 A1 ES8608872 A1 ES 8608872A1
Authority
ES
Spain
Prior art keywords
endotoxin
extract
pyridine
treatment
piridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES536167A
Other languages
English (en)
Spanish (es)
Other versions
ES536167A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ribi Immunochem Research Inc
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of ES536167A0 publication Critical patent/ES536167A0/es
Publication of ES8608872A1 publication Critical patent/ES8608872A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ES536167A 1983-09-23 1984-09-21 Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada. Expired ES8608872A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (2)

Publication Number Publication Date
ES536167A0 ES536167A0 (es) 1986-07-16
ES8608872A1 true ES8608872A1 (es) 1986-07-16

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
ES536167A Expired ES8608872A1 (es) 1983-09-23 1984-09-21 Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.

Country Status (23)

Country Link
US (1) US4663306A (show.php)
JP (1) JPS60120817A (show.php)
KR (1) KR870000843B1 (show.php)
AT (1) AT385659B (show.php)
AU (1) AU566234B2 (show.php)
BE (1) BE900650A (show.php)
CA (1) CA1244765A (show.php)
CH (1) CH664897A5 (show.php)
DE (1) DE3434766C2 (show.php)
DK (1) DK446684A (show.php)
ES (1) ES8608872A1 (show.php)
FI (1) FI843716L (show.php)
FR (1) FR2552326B1 (show.php)
GB (1) GB2149301B (show.php)
HU (1) HU192585B (show.php)
IL (1) IL73034A (show.php)
IN (1) IN157240B (show.php)
IT (1) IT1179444B (show.php)
NL (1) NL8402902A (show.php)
NO (1) NO843776L (show.php)
NZ (1) NZ209635A (show.php)
SE (1) SE8404707L (show.php)
ZA (1) ZA847405B (show.php)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
CA2170142C (en) * 1993-08-27 2010-05-25 Jose M. Wade Composition and method for stimulation of reproductive performance
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
KR100533576B1 (ko) 1997-08-05 2005-12-05 바이오니취 라이프 사이언시즈 인코포레이티드 세포증식 및 세포사멸 조절용 조성물 및 방법
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
CN1230184C (zh) * 1998-07-16 2005-12-07 东市郎 以细菌的菌体成分为有效成分的癌免疫治疗用制剂
HUP0300627A3 (en) * 1999-12-13 2005-11-28 Bioniche Life Sciences Inc Bel Therapeutically useful synthetic oligonucleotides
CA2395493C (en) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
MXPA03000278A (es) * 2000-07-11 2004-04-05 Bayer Ag Uso de cepas de parapoxvirus ovis frente a fibrosis de organos.
WO2003074079A1 (fr) * 2002-03-05 2003-09-12 Cell-Medicine, Inc. Adjuvant immunologique a base de tissus solidifies
JP4726485B2 (ja) * 2002-08-02 2011-07-20 大日本住友製薬株式会社 細菌細胞壁骨格成分製剤
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
US20060127518A1 (en) * 2003-09-05 2006-06-15 Shenyang Sunbellcom Bio-Pharmaceutical Co. Red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
EP1741438A4 (en) * 2004-04-22 2009-08-26 Dainippon Sumitomo Pharma Co PHARMACEUTICAL PREPARATION CONTAINING SKELETAL COMPONENT OF BACTERIAL CELL WALL
EP3711768A1 (en) 2013-04-18 2020-09-23 Immune Design Corp. Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
CA2950945A1 (en) 2014-06-17 2015-12-23 Xycrobe Therapeutics, Inc. Genetically modified bacteria and methods for genetic modification of bacteria
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
US20210040055A1 (en) * 2017-08-17 2021-02-11 University Of Delaware Furan based compositions and methods of making thereof
JP2023533202A (ja) 2020-06-23 2023-08-02 クラウン ラボラトリーズ,インコーポレイテッド プロバイオティクス皮膚製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (show.php) * 1972-06-20 1973-12-27
FR2269962B1 (show.php) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白wenac及びその製造法
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
ATA302384A (de) 1987-10-15
FR2552326A1 (fr) 1985-03-29
FI843716A0 (fi) 1984-09-21
AU566234B2 (en) 1987-10-15
FR2552326B1 (fr) 1988-05-13
HUT35521A (en) 1985-07-29
JPS6254775B2 (show.php) 1987-11-17
HU192585B (en) 1987-06-29
NZ209635A (en) 1989-01-27
AU3340084A (en) 1985-03-28
SE8404707D0 (sv) 1984-09-20
IT8448894A0 (it) 1984-09-24
CA1244765A (en) 1988-11-15
DK446684A (da) 1985-03-24
ES536167A0 (es) 1986-07-16
FI843716A7 (fi) 1985-03-24
KR870000843B1 (ko) 1987-04-25
GB8423993D0 (en) 1984-10-31
DE3434766A1 (de) 1986-04-30
SE8404707L (sv) 1985-03-24
GB2149301A (en) 1985-06-12
AT385659B (de) 1988-05-10
DE3434766C2 (de) 1987-05-14
NO843776L (no) 1985-03-25
DK446684D0 (da) 1984-09-19
KR850002404A (ko) 1985-05-13
FI843716L (fi) 1985-03-24
IN157240B (show.php) 1986-02-15
ZA847405B (en) 1985-05-29
CH664897A5 (de) 1988-04-15
GB2149301B (en) 1988-06-22
US4663306A (en) 1987-05-05
BE900650A (fr) 1985-03-21
IL73034A (en) 1988-11-15
JPS60120817A (ja) 1985-06-28
NL8402902A (nl) 1985-04-16
IT1179444B (it) 1987-09-16

Similar Documents

Publication Publication Date Title
ES8608872A1 (es) Un metodo para preparar una composicion terapeutica a base de un extracto soluble en piridina y una endotoxina destosificada refinada.
ES8101887A1 (es) Procedimiento para obtener una preparacion farmaceutica que comprende un glicorido cardiaco con un revertimiento de po- limero
IT1004479B (it) Metodo per recuperare ilcatalizzato re nella preparazione di acido tereftalico
ATE40992T1 (de) Verfahren zur herstellung beweglicher pasten waschaktiver alpha-sulfofettsaeureestersalze hohen feststoffgehalts.
WO2018077309A1 (zh) 一种脂溶性咖啡酸脂肪酸结构油脂及其制备方法与应用
DE3761093D1 (de) Herstellungsverfahren von aethyltrifluoracetat.
DE3585713D1 (de) Immunoverstaerker und verfahren zu ihrer herstellung.
CH512835A (de) Verfahren zur Herstellung elektrischer Verbindungselemente und zu ihrer Befestigung an elektrischen Leitern sowie Vorrichtung zur Ausführung des Verfahrens
GB724256A (en) Improvements in the production of esters of pyridine carboxylic acids
BE768647A (fr) Procede d'extraction de la fraction insaponifiable de corps gras naturels
GB1427253A (en) Antilipemic composition containing unsaponifiable matter of soybean oil
CA937935A (en) Process for the preparation of benzimidazole-2-carbamic acid esters
JPS5242815A (en) Process for preparation of carboxylic acid esters
JPS5497692A (en) Linear mannan
YOKOKAWA Studies on the Oils of Basidiomycetes. IV. On the Oils of Masutake (Polyporus sulphureus, Fr.) and Kikurage (Auricularia auricula jadae, Quel)
GT196912430A (es) Proceso
JPS55153562A (en) Preparation of soybean protein
AU438234B2 (en) PROCESS FORTHE PREPARATION OF BENZIMIDAZOLE CARBAMIC acid esters
IT1054501B (it) Processo per la preparazione di esteri del acido i.4 naftalendi carbossilico
BE764837A (fr) Nouveaux esters d'acide phosphorique, leur procede de preparation et leur application comme insectides acaricides et nematocides
AU1676170A (en) PROCESS FORTHE PREPARATION OF BENZIMIDAZOLE CARBAMIC acid esters
CA922572A (en) Method of preparing vegetable concentrate and concentrate thereby produced
JPS5398918A (en) Preparation of gamma-pyrone derivatives
JPS5575401A (en) Polysaccharide and preparation thereof
AU1935970A (en) Process forthe preparation of branched epoxyalkyl esters